Previous Close | 6.06 |
Open | 6.20 |
Bid | 5.75 x 3000 |
Ask | 6.10 x 1200 |
Day's Range | 5.71 - 6.29 |
52 Week Range | 4.61 - 55.47 |
Volume | |
Avg. Volume | 1,691,018 |
Market Cap | 407.318M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
With me on the call today are our chief executive officer, Rajeev Singh; and our chief financial officer, Steve Barnes. Shantanu Nundy, our chief medical officer, will join us for the question-and-answer portion of the call.
Accolade (ACCD) delivered earnings and revenue surprises of -17.39% and 1.82%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?